Fanny Lanternier Selected Research

Monoclonal Antibodies

12/2022	Pre-exposure prophylaxis with tixagevimab and cilgavimab (Evusheld) for COVID-19 among 1112 severely immunocompromised patients.
1/2022	Early treatment with sotrovimab monoclonal antibody in kidney transplant recipients with Omicron infection.
1/2022	COVID-19 outbreak in vaccinated patients from a haemodialysis unit: antibody titres as a marker of protection from infection.
9/2013	Incidence and risk factors of Legionella pneumophila pneumonia during anti-tumor necrosis factor therapy: a prospective French study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fanny Lanternier Research Topics

Disease

40	Infections 04/2024 - 12/2008
12	Aspergillosis 03/2024 - 03/2009
10	Mycoses (Diseases, Fungus) 11/2022 - 02/2010
8	Neoplasms (Cancer) 03/2024 - 03/2013
7	Diabetes Mellitus 02/2023 - 02/2012
7	Mucormycosis 01/2022 - 02/2012
6	Invasive Fungal Infections 11/2022 - 08/2011
5	COVID-19 02/2024 - 12/2021
5	Hematologic Neoplasms (Hematological Malignancy) 11/2023 - 10/2015
3	Candidiasis (Moniliasis) 11/2023 - 12/2013
3	Pulmonary Aspergillosis 01/2023 - 06/2020
3	Chronic Granulomatous Disease 01/2023 - 12/2013
3	autosomal recessive Candidiasis familial chronic mucocutaneous 01/2023 - 02/2015
3	Chronic Mucocutaneous Candidiasis 01/2023 - 12/2013
3	Tinea (Ringworm) 11/2022 - 02/2015
3	Bronchiectasis 12/2019 - 03/2012
3	Trichophyton infection 07/2015 - 12/2013
2	scedosporiosis 03/2024 - 07/2023
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 03/2024 - 03/2021
2	Myelitis 01/2024 - 09/2022
2	Fungemia 01/2023 - 05/2021
2	Job Syndrome (Hyper-IgE Syndrome) 01/2023 - 01/2023
2	Cryptococcosis 11/2022 - 12/2015
2	Meningitis 03/2021 - 08/2020
2	Immune Reconstitution Inflammatory Syndrome 01/2021 - 10/2019
2	Histoplasmosis 01/2021 - 08/2012
2	Communicable Diseases (Infectious Diseases) 01/2021 - 05/2020
2	Bacterial Infections (Bacterial Infection) 01/2021 - 03/2012
2	Cryptococcal Meningitis 08/2020 - 10/2019
2	Liver Cirrhosis (Hepatic Cirrhosis) 04/2019 - 10/2007
2	Diarrhea 01/2017 - 07/2011
2	Visceral Leishmaniasis (Kala Azar) 01/2016 - 01/2013
2	Pneumonia (Pneumonitis) 09/2013 - 02/2010
2	Mastocytosis 05/2013 - 12/2010
2	Cellulitis 10/2008 - 12/2004
1	Multiple Organ Failure (MODS) 04/2024
1	Critical Illness (Critically Ill) 04/2024
1	cell-associated neurotoxicity 03/2024
1	Cytokine Release Syndrome 03/2024
1	Multiple Myeloma 03/2024
1	Tuberculosis (Tuberculoses) 02/2024
1	Extrapulmonary Tuberculosis 02/2024
1	Paraplegia (Spastic Paraplegia) 01/2024
1	Clinical Deterioration 01/2024
1	Malaria 11/2023
1	Hemolysis 11/2023
1	Inflammation (Inflammations) 11/2023

Drug/Important Bio-Agent (IBA)

7	Voriconazole (Vfend)FDA LinkGeneric 04/2024 - 03/2009
6	Proteins (Proteins, Gene)FDA Link 01/2023 - 10/2013
5	posaconazole FDA Link 11/2019 - 12/2009
5	liposomal amphotericin B FDA Link 12/2018 - 03/2013
4	Antifungal AgentsIBA 03/2024 - 12/2018
4	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2023 - 07/2019
4	Monoclonal AntibodiesIBA 12/2022 - 09/2013
4	Virulence Factors (Pathogenicity Factors)IBA 03/2021 - 01/2019
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 09/2013
3	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2024 - 01/2017
3	AntigensIBA 03/2024 - 09/2013
3	olorofimIBA 03/2024 - 01/2023
3	AzolesIBA 01/2023 - 06/2020
3	VaccinesIBA 12/2022 - 12/2021
3	Interleukin-17 (Interleukin 17)IBA 11/2022 - 12/2013
3	Immunoglobulins (Immunoglobulin)IBA 01/2021 - 03/2012
2	ibrutinibIBA 03/2024 - 03/2021
2	tixagevimabIBA 02/2024 - 12/2022
2	cilgavimab and tixagevimab drug combinationIBA 02/2024 - 12/2022
2	cilgavimabIBA 02/2024 - 12/2022
2	RezafunginIBA 11/2023 - 01/2023
2	CD40 Ligand (CD40L)IBA 11/2022 - 01/2017
2	Interferon-gamma (Interferon, gamma)IBA 01/2022 - 01/2020
2	InterferonsIBA 01/2022 - 12/2013
2	Immunoglobulin G (IgG)IBA 01/2022 - 01/2021
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2021
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 09/2013
2	Nucleic AcidsIBA 01/2021 - 08/2020
2	isavuconazoleIBA 10/2019 - 12/2018
2	Amphotericin B (Amphotericin)FDA LinkGeneric 01/2019 - 12/2018
2	Immunosuppressive Agents (Immunosuppressants)IBA 12/2018 - 04/2013
2	Carbapenems (Carbapenem Antibiotics)IBA 02/2010 - 11/2009
1	Flucytosine (Ancobon)FDA Link 03/2024
1	acalabrutinibIBA 03/2024
1	B-Cell Maturation AntigenIBA 03/2024
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 03/2024
1	Bispecific AntibodiesIBA 03/2024
1	Antimalarials (Antimalarial Agents)IBA 11/2023
1	artemisinin (artemisinine)IBA 11/2023

Therapy/Procedure

18	Therapeutics 03/2024 - 03/2009
8	Organ Transplantation 11/2023 - 02/2012
6	Drug Therapy (Chemotherapy) 11/2021 - 01/2013
6	Transplantation 03/2021 - 02/2012
4	Hematopoietic Stem Cell Transplantation 11/2023 - 02/2010
3	Aftercare (After-Treatment) 12/2022 - 01/2016
3	Highly Active Antiretroviral Therapy (HAART) 12/2015 - 10/2007
2	Kidney Transplantation 10/2023 - 07/2011
2	Cell Transplantation 01/2021 - 01/2021
2	Biological Therapy 04/2019 - 09/2013
2	Splenectomy 09/2011 - 12/2008
1	Oral Administration 03/2024
1	Liver Transplantation 02/2024
1	Artificial Respiration (Mechanical Ventilation) 01/2024